MeOSuc-AAPV-AMC is a fluorogenic substrate for human leukocyte and porcine pancreatic elastase.
CAT No: 10-101-307
CAS No:72252-90-5
Synonyms/Alias:MeOSuc-Ala-Ala-Pro-Val-7-Amino-4-Methylcoumarin; MeOSuc-AAPV-AMC
Chemical Name:methyl 4-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-3-methyl-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoate
MeoSuc-Ala-Ala-Pro-Val-AMC is a synthetic peptide substrate widely recognized for its utility in enzymology and protease research. Structurally, it consists of a tetrapeptide sequence (Ala-Ala-Pro-Val) linked to a 7-amino-4-methylcoumarin (AMC) fluorogenic reporter, with a methoxysuccinyl (MeoSuc) group at the N-terminus to enhance substrate specificity. This compound is especially valued for its ability to facilitate the quantitative analysis of proteolytic activity by releasing a fluorescent signal upon enzymatic cleavage. Its tailored design enables researchers to dissect the activity and selectivity of serine proteases, particularly those in the chymotrypsin and elastase families, making it a critical reagent in both basic and applied biochemical studies.
Enzyme activity assays: MeoSuc-Ala-Ala-Pro-Val-AMC serves as a highly sensitive substrate for measuring the activity of specific serine proteases, such as elastase and proteinase families. Upon enzymatic hydrolysis at the peptide bond adjacent to the AMC moiety, a strong fluorescent signal is generated, allowing for real-time kinetic analysis of enzyme function. This property is essential for characterizing enzyme kinetics, determining catalytic efficiencies, and comparing protease activities under various experimental conditions.
Inhibitor screening: The substrate's well-defined cleavage properties make it ideal for high-throughput screening of protease inhibitors. By monitoring the fluorescence released during substrate hydrolysis, researchers can rapidly evaluate the potency and specificity of candidate inhibitors. This application is particularly important in drug discovery and biochemical research, where identifying selective modulators of protease activity is crucial for understanding regulatory pathways and developing targeted molecular tools.
Substrate specificity profiling: MeoSuc-Ala-Ala-Pro-Val-AMC is frequently employed to investigate the substrate preferences of serine proteases. By comparing the rates of hydrolysis of this and related peptide substrates, scientists can map the active site specificity and substrate recognition motifs of target enzymes. Such studies provide valuable insights into enzyme-substrate interactions, helping to elucidate the molecular determinants of proteolytic selectivity and guiding the design of improved substrates or inhibitors.
Protease mechanism studies: The fluorogenic nature of the AMC moiety enables detailed mechanistic investigations into protease function. Researchers can use the substrate to monitor reaction intermediates, assess the impact of mutations on catalysis, and dissect the stepwise process of peptide bond hydrolysis. These mechanistic insights are fundamental for advancing our understanding of enzyme catalysis and for engineering proteases with altered or enhanced activities.
Biochemical assay development: The robust and quantifiable fluorescent readout provided by this substrate supports the development of reliable and reproducible assays for laboratory and industrial applications. Its use facilitates the standardization of protease activity measurements, quality control of enzyme preparations, and validation of assay platforms. By enabling sensitive detection of enzymatic activity, MeoSuc-Ala-Ala-Pro-Val-AMC contributes to the advancement of biochemical research, diagnostics development, and process optimization in biotechnology settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.